NR1I3通过增强PCK1-介导的葡萄糖生成来抑制结直肠癌的生长
Huanying Shi1, Zimei Wu1, Jiafeng Liu1
1Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chemico-biological interactions
|September 10, 2025
概括
核受体子家族1组I成员3 (NR1I3) 通过将新陈代谢从糖解转移到葡萄糖生成来抑制结肠直肠癌 (CRC) 的生长. 低NR1I3水平与生存率差相关,这表明它是治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢过程中的代谢.
背景情况:
- 核受体子家族1组I成员3 (NR1I3) 与各种癌症有关.
- NR1I3在结直肠癌 (CRC) 进展中的作用及其对葡萄糖生成的影响仍然不清楚.
研究的目的:
- 研究NR1I3在结直肠癌 (CRC) 细胞中的功能作用.
- 为了确定NR1I3是否抑制CRC生长并影响葡萄糖生成.
- 探索NR1I3诱导在CRC中的治疗潜力.
主要方法:
- 西部涂抹,流细胞计,细胞增殖,殖民地形成试验,qRT-PCR.
- 葡萄糖生成试验和体内动物模型.
- 使用CITCO进行NR1I3的药理诱导.
主要成果:
- 在CRC组织中,NR1I3经常下调,与患者的生存率差相关.
- 通过阻止细胞循环,NR1I3抑制了CRC细胞的增殖,并诱导了细胞亡.
- 用CITCO对NR1I3的药理诱导减少了CRC的生长,并诱导了亡.
- NR1I3促进葡萄糖生成,并通过与PCK1相互作用来抑制糖解,导致ATP耗尽和细胞生长停止.
结论:
- NR1I3抑制了结直肠癌 (CRC) 的进展.
- 通过通过PCK1.1,NR1I3通过重新编程细胞代谢从糖解到葡萄糖生成来抑制CRC.
- NR1I3及其代谢途径代表了CRC的潜在治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Inhibition of Cdk Activity
5.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.4K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Negative Regulator Molecules
38.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K


